Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Transitional Cell Cancer of Renal Pelvis and Ureter × padeliporfin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urogenital Neoplasms 2 Prostatic Neoplasms 2 Prostatic Diseases 2 Neoplasms by Site 2 Neoplasms 2 Male Urogenital Diseases 2 Genital Neoplasms, Male 2 Genital Diseases, Male 2 Carcinoma 2 Transitional Cell Cancer of Renal Pelvis and Ureter 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04620239 2026-02-04

UCM301

Steba Biotech S.A.

Phase 3 Recruiting

Transitional Cell Cancer of Renal Pelvis and Ureter

Data powered by HemOnc (CC BY 4.0) Colophon ⚡